Takeda’s rADAMTS13 Earns Favorable CHMP Opinion for cTTP Treatment
June 3, 2024 Osaka, Japan & Cambridge, Mass., United States Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended…